Senator Durbin Asks Medical Associations to Endorse Mandatory Opioid CME –…
Following last month's letter to the Pharmaceutical Research and Manufacturers of America (PhRMA), asking the group to "take…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
CMS Proposed Patient Relationship Categories for MACRA
Patient engagement and patient satisfaction have been a core principle of healthcare reform under ACA and MACRA. The Centers for…
The Importance of Being Private – OCR Intensifies Enforcement Efforts
The Department of Health and Human Services' Office of Civil Rights is stepping up its enforcement efforts. Phase 2 of its HIPAA…
E&C Committee Hearing on CMS Medicare Part B Demonstration
The United States House Committee on Energy and Commerce, Subcommittee on Health held a hearing on Tuesday, May 17,…
Vermont: First State to Pass Pharmaceutical Cost Transparency Bill
Vermont is soon to be the first state in the nation that requires pharmaceutical manufacturers to explain the reasons…
Growing Like Weeds – MedTech Europe Adopts New Code of Ethical…
Europe adopted a new Code of Ethical Business Practice late last year. This article explores the purpose of the new Code,…
Aegerion Pharmaceuticals Reaches Settlement Agreements in Principle with…
Aegerion Pharmaceuticals has reached agreements in principle with the Department of Justice ("DOJ") and the Securities and…
Willis-Knighton Antitrust Suit Allowed to Proceed
Consolidation is happening in insurers and health systems throughout the country. A recent legal case in Louisiana sheds…
The American College of Cardiology Scientific Session on MACRA
The American College of Cardiology recently held the 65th Annual Scientific Session and Expo, where several sessions focused on…
Pharmaceutical Summit on Business & Compliance Issues in Managed…
The Pharmaceutical Summit on Business and Compliance Issues in Managed Markets is set to take place June 8 through June 9, 2016,…